Your trusted source for investing success

Tag: European Union

Aurora and WeedMD Announce Strategic Agreement

Aurora and WeedMD Announce Strategic Agreement

Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX-V:ACB) (OTCQX:ACBFF) (Frankfurt:21P; WKN:A1C4WM) andWeedMD Inc. (TSX-V:WMD) are pleased to announce that the companies have entered into a strategic relationship whereby WeedMD will provide wholesale dried medical cannabis to Aurora, and Aurora will provide best in class patient education services for WeedMD through its

dynaCERT Announces Multiple European Dealership Agreements

dynaCERT Announces Multiple European Dealership Agreements

dynaCERT Inc. (TSXV:DYA; OTC:DYFSF) (“dynaCERT” or the “Company”) is pleased to announce that the company has signed multiple dealership agreements in Europe.  These dealers are located in Germany, Austria, Switzerland, Benelux, Italy, Spain, United Kingdom, France and Slovenia.
The dealers will stock and resell the HydraGEN™ products in their local markets.

Global Cannabis Submits Trademark For “Pain To Strain”

Global Cannabis Submits Trademark For “Pain To Strain”

Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it has submitted a word trademark application to the US Patent and Trademark Office for Pain To Strain.

The Pain To Strain trademark will cover GCAC’s business methodology

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

MGX Acquires Additional 4,718 Claims at Paradox Basin

MGX Acquires Additional 4,718 Claims at Paradox Basin

MGX Minerals (CSE:XMG) has provided a project development update for its Paradox basin petrolithium project.

The company has begun unitization of designated oil and gas leases and the staking of overlying mineral claims located contiguous to its Lisbon Valley mineral claims. The purpose of the unitization is to eliminate property boundaries,

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has presented three abstracts at the American Association for Cancer Research (AACR) Annual Meeting. These abstracts are all focused on pre-clinical research to elucidate the mechanism of action (MOA) of

MGX Minerals Files Q2 Results, No Details in NR

MGX Minerals Files Q2 Results, No Details in NR

MGX Minerals (CSE:XMG) has filed an annual information form with Canadian securities authorities. MGX has also filed its unaudited interim financial statements for the three and six months ended January 31, 2017 and 2016, together with accompanying management’s discussion and analysis.

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network